Study met its primary objective demonstrating excellent safety and tolerability, of RESP-X in patients with NCFB colonised with Pseudomonas ...

Panelists discuss how future bronchiectasis research will focus on precision medicine, identify treatable traits, and expand networks of Centers of Excellence to provide advanced care and clinical ...

Highly symptomatic bronchiectasis patients have increased exacerbation risks, regardless of previous exacerbation history or disease severity. Current guidelines do not recommend preventive treatments ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. This study cohort was made up of 71.3% U.K. patients ...

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Renovion Inc., a biopharmaceutical company focused on restoring lung health in patients with bronchiectasis and other lung diseases, announced that adult patient ...

September 10, 2012 (Vienna, Austria) — An easy-to-use 7-point scale to evaluate disease severity in patients with noncystic fibrosis bronchiectasis has been developed. In a validation study, the score ...

An international research team led by Nanyang Technological University, Singapore (NTU Singapore) has found that patients with the lung disease bronchiectasis also often display sensitivity to ...

Smoking, pulmonary hypertension, and a decline in lung function are associated with an increased risk of death in people with chronic obstructive pulmonary disease (COPD). Now researchers in Spain ...

Please provide your email address to receive an email when new articles are posted on . Treatment with brensocatib for 24 weeks significantly prolonged time to first pulmonary exacerbation in patients ...

Bronchiectasis is independently associated with mortality risk among patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), Spanish research shows. The study authors say the ...